I/O

1 stories · following the connections

Business

Sorrento Therapeutics Welcomes Jiong Shao as Chief Financial Officer and Reaffirms Intent to Seek Nasdaq/HKSE Dual Listing in 2018

By Nasdaq OMXMar 19, 2018, 12:00 PM UTC